BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9344857)

  • 21. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways.
    Feller SM; Knudsen B; Hanafusa H
    Oncogene; 1995 Apr; 10(8):1465-73. PubMed ID: 7731701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton.
    Li W; Fan J; Woodley DT
    Oncogene; 2001 Oct; 20(44):6403-17. PubMed ID: 11607841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
    Yoon SY; Koh WS; Lee MK; Park YM; Han MY
    Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner.
    Fan MM; Tamburic L; Shippam-Brett C; Zagrodney DB; Astell CR
    Virology; 2001 Dec; 291(2):285-91. PubMed ID: 11878897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
    Xu XX; Yi T; Tang B; Lambeth JD
    Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes.
    Jones N; Blasutig IM; Eremina V; Ruston JM; Bladt F; Li H; Huang H; Larose L; Li SS; Takano T; Quaggin SE; Pawson T
    Nature; 2006 Apr; 440(7085):818-23. PubMed ID: 16525419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
    Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
    J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.
    Jones N; Dumont DJ
    Oncogene; 1998 Sep; 17(9):1097-108. PubMed ID: 9764820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II stimulates serine phosphorylation of the adaptor protein Nck: physical association with the serine/threonine kinases Pak1 and casein kinase I.
    Voisin L; Larose L; Meloche S
    Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):217-23. PubMed ID: 10377265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF-2 facilitates binding of SH3 domain of PLC-gamma1 to vinculin and SH2 domains to FGF receptor in corneal endothelial cells.
    Park SY; Barron E; Suh PG; Ryu SH; Kay EP
    Mol Vis; 1999 Aug; 5():18. PubMed ID: 10459043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
    Tanaka M; Gupta R; Mayer BJ
    Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways.
    Tu Y; Li F; Wu C
    Mol Biol Cell; 1998 Dec; 9(12):3367-82. PubMed ID: 9843575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins.
    Buday L
    Biochim Biophys Acta; 1999 Jul; 1422(2):187-204. PubMed ID: 10393272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck.
    Lu W; Katz S; Gupta R; Mayer BJ
    Curr Biol; 1997 Feb; 7(2):85-94. PubMed ID: 9024622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A uNick protein].
    Labelle-Côté M; Larose L
    Med Sci (Paris); 2011; 27(8-9):746-52. PubMed ID: 21880263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment.
    Meisenhelder J; Hunter T
    Mol Cell Biol; 1992 Dec; 12(12):5843-56. PubMed ID: 1448108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SH3-mediated targeting of Wrch1/RhoU by multiple adaptor proteins.
    Risse SL; Vaz B; Burton MF; Aspenström P; Piekorz RP; Brunsveld L; Ahmadian MR
    Biol Chem; 2013 Mar; 394(3):421-32. PubMed ID: 23183748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.